This independent lab test confirms Retatrutide 15mg from Hydro Research Peptides at 99.779% purity. The analysis was conducted by Janoshik Labs on March 18, 2025. The tested sample contained 17.07mg of the stated peptide compound, representing a +13.8% overage.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. Studies indicate potential applications in obesity and type 2 diabetes research. A purity level of 99.779% indicates high-grade synthesis with minimal contamination.
The full certificate of analysis is available for verification at www.janoshik.com/verify/ using the unique key 2EASET9JG5VV.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.